Elsevier

Fertility and Sterility

Volume 105, Issue 1, January 2016, Pages 149-155.e1
Fertility and Sterility

Original article
Vasomotor and sexual symptoms in older Australian women: a cross-sectional study

https://doi.org/10.1016/j.fertnstert.2015.09.017Get rights and content
Under an Elsevier user license
open archive

Objectives

To determine the prevalence and severity of vasomotor symptoms (VMS) and sexual symptoms in community-dwelling older women, and to explore factors associated with VMS.

Design

Population-based cross-sectional study.

Setting

Not applicable.

Participant(s)

A total of 1,548 women aged 65–79 years.

Intervention(s)

None.

Main Outcomes Measure(s)

The presence and self-rated severity of VMS (hot flashes, night sweats, or sweating), and sexual symptoms (intimacy, desire, and vaginal dryness) were determined with the use of the Menopause Quality of Life (MenQOL) questionnaire.

Result(s)

All items of the vasomotor and the sexual MenQOL domains were completed by 1,532 and 1,361 of the study participants, respectively. Menopausal hormone therapy (MHT) use was reported by 6.2% of the women, and 6.9% reported using vaginal estrogen. Among the 1,426 women not using MHT, at least 1 VMS was reported by 32.8%. The prevalence of VMS rated as moderately to severely bothersome was 3.4%. A total of 54.4% of currently partnered women had sexual symptoms, and 32.5% reported vaginal dryness during intercourse in the past month. In the multivariate analysis, factors significantly associated with VMS were age, obesity, being a caregiver for another person, and bilateral oophorectomy.

Conclusion(s)

VMS and vaginal atrophy symptoms are common in community-dwelling older women, but they are predominantly untreated. The degree of distress caused by sexual symptoms among older women needs further exploration.

Key Words

Vasomotor symptoms
older women
menopause

Cited by (0)

B.M.Z. has nothing to disclose. R.J.B. has nothing to disclose. B.B. has nothing to disclose. S.R.D. has been a consultant to Trimel Pharmaceuticals, has received honoraria from Abbott Pharmaceuticals, and has research support from Lawley Pharmaceuticals.

Supported by International Menopause Society Research Bursary, Monash University Postgraduate Research Scholarship (to B.M.Z.) and Australian NHMRC Principal Research Fellow grant (no 1041853 to S.R.D.).